Given that EBV is associated with several other malignancies including nasopharyngeal carcinoma and lymphoma, future studies are needed to determine whether the miR-BART20-3p–PPARα regulatory axis operates similarly in other EBV-associated cancers. Here, PPARA is linked to lymphoma.